Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Dec-12 5:07 PM View:  | Casdin Alexander W. Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 216,000 | $8.00 | $1,728,000.00 | (100%) 216.0K to 0 | 0% |
| 20-Dec-12 5:05 PM View: | Carota Mark Vice President, Operations | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 188,285 | $8.00 | $1,506,280.00 | (100%) 188.28K to 0 | 0% |
| 20-Dec-12 5:16 PM View: | Haft Jay M Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 13,750 | $8.00 | $110,000.00 | (100%) 13.75K to 0 | 0% |
| 20-Dec-12 5:12 PM View: | Doman Robert F President and CEO Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 528,400 | $8.00 | $4,227,200.00 | (100%) 528.4K to 0 | 0% |
| 20-Dec-12 5:25 PM View: | Moliteus Magnus Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 58,500 | $8.00 | $468,000.00 | (100%) 58.5K to 0 | 0% |
| 20-Dec-12 5:10 PM View: | Christopher Richard VP Finance & CFO | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 276,012 | $8.00 | $2,208,100.00 | (100%) 276.01K to 0 | 0% |
| 20-Dec-12 5:16 PM View: | Haft Jay M Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 50,250 | $8.00 | $402,000.00 | (51%) 98.5K to 48.25K | 0% |
| 20-Dec-12 4:58 PM View: | Altomari Alfred Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 20,000 | $8.00 | $160,000.00 | (100%) 20.0K to 0 | < 1% |
| 20-Dec-12 5:12 PM View: | Doman Robert F President and CEO Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 138,286 | $8.00 | $1,106,290.00 | (20%) 686.44K to 548.15K | 0% |
| 20-Dec-12 5:01 PM View: | Bartash David M Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 64,000 | $8.00 | $512,000.00 | (100%) 64.0K to 0 | < 1% |
| 20-Dec-12 5:31 PM View: | Todisco Michael Vice President, Controller | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 170,320 | $8.00 | $1,362,560.00 | (100%) 170.32K to 0 | 0% |
| 20-Dec-12 5:23 PM View: | Marcus Stuart L VP, Sc. Aff & CMO | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 113,119 | $8.00 | $904,952.00 | (100%) 113.12K to 0 | 0% |
| 20-Dec-12 5:28 PM View: | Odell William F Exec. VP Sales and Marketing | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 272,710 | $8.00 | $2,181,680.00 | (100%) 272.71K to 0 | 0% |
| 20-Dec-12 5:16 PM View: | Haft Jay M Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 34,500 | $8.00 | $276,000.00 | (72%) 48.25K to 13.75K | 0% |
| 20-Dec-12 5:20 PM View: | Lundahl Scott L VP, Regulatory Affairs & IP | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 210,214 | $8.00 | $1,681,710.00 | (100%) 210.21K to 0 | 0% |
| 20-Dec-12 5:12 PM View: | Doman Robert F President and CEO Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 19,750 | $8.00 | $158,000.00 | (4%) 548.15K to 528.4K | 0% |
| 20-Dec-12 5:37 PM View: | Wurzer David M Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 21,000 | $8.00 | $168,000.00 | (100%) 21.0K to 0 | 0% |
| 20-Dec-12 5:19 PM View: | Hondros Paul J. Director | DUSA Pharmaceuticals Inc. (DUSA) | 20-Dec-12 | Disposition (change in control) | 16,000 | $8.00 | $128,000.00 | (100%) 16.0K to 0 | 0% |
| 13-Nov-12 2:05 PM View: | Christopher Richard VP Finance & CFO | DUSA Pharmaceuticals Inc. (DUSA) | 13-Nov-12 | Option Exercise | 7,500 | $1.60 | $12,000.00 | 3% 268.51K to 276.01K | |
| 02-Jul-12 9:46 AM View: | Haft Jay M Director | DUSA Pharmaceuticals Inc. (DUSA) | 30-Jun-12 | Grant | 8,000 | -- | -- | 9% 90.5K to 98.5K | |
| 02-Jul-12 9:54 AM View: | Wurzer David M Director | DUSA Pharmaceuticals Inc. (DUSA) | 30-Jun-12 | Grant | 8,000 | -- | -- | 62% 13.0K to 21.0K | |
| 02-Jul-12 9:51 AM View: | Moliteus Magnus Director | DUSA Pharmaceuticals Inc. (DUSA) | 30-Jun-12 | Grant | 8,000 | -- | -- | 16% 50.5K to 58.5K | |
| 02-Jul-12 9:38 AM View: | Altomari Alfred Director | DUSA Pharmaceuticals Inc. (DUSA) | 30-Jun-12 | Grant | 8,000 | -- | -- | 67% 12.0K to 20.0K | |
| 02-Jul-12 9:49 AM View: | Hondros Paul J. Director | DUSA Pharmaceuticals Inc. (DUSA) | 30-Jun-12 | Grant | 8,000 | -- | -- | 100% 8.0K to 16.0K | |
| 02-Jul-12 9:43 AM View: | Casdin Alexander W. Director | DUSA Pharmaceuticals Inc. (DUSA) | 30-Jun-12 | Grant | 8,000 | -- | -- | 4% 208.0K to 216.0K | |
| 02-Jul-12 9:40 AM View: | Bartash David M Director | DUSA Pharmaceuticals Inc. (DUSA) | 30-Jun-12 | Grant | 8,000 | -- | -- | 14% 56.0K to 64.0K | |
| 11-May-12 9:46 AM View: | Marcus Stuart L VP, Sc. Aff & CMO | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-12 | Payment of Exercise | 1,172 | $6.13 | $7,184.36 | (1%) 114.29K to 113.12K | (30%) |
| 11-May-12 9:44 AM View: | Lundahl Scott L VP, Regulatory Affairs & IP | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-12 | Payment of Exercise | 872 | $6.13 | $5,345.36 | (< 1%) 211.09K to 210.21K | (30%) |
| 11-May-12 9:50 AM View: | Odell William F Exec. VP Sales and Marketing | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-12 | Payment of Exercise | 1,030 | $6.13 | $6,313.90 | (< 1%) 273.74K to 272.71K | (30%) |
| 11-May-12 9:52 AM View: | Todisco Michael Vice President, Controller | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-12 | Payment of Exercise | 872 | $6.13 | $5,345.36 | (< 1%) 171.19K to 170.32K | (30%) |
| 11-May-12 9:37 AM View: | Carota Mark Vice President, Operations | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-12 | Payment of Exercise | 872 | $6.13 | $5,345.36 | (< 1%) 189.16K to 188.28K | (30%) |
| 11-May-12 9:42 AM View: | Doman Robert F President and CEO Director | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-12 | Payment of Exercise | 1,506 | $6.13 | $9,231.78 | (< 1%) 687.94K to 686.44K | (30%) |
| 11-May-12 9:40 AM View: | Christopher Richard VP Finance & CFO | DUSA Pharmaceuticals Inc. (DUSA) | 09-May-12 | Payment of Exercise | 1,030 | $6.13 | $6,313.90 | (< 1%) 269.54K to 268.51K | (30%) |
| 19-Mar-12 10:45 AM View: | Lundahl Scott L VP, Regulatory Affairs & IP | DUSA Pharmaceuticals Inc. (DUSA) | 16-Mar-12 | Option Exercise | 17,500 | $1.60 | $28,000.00 | 8% 211.09K to 228.59K | |
| 19-Mar-12 10:45 AM View: | Lundahl Scott L VP, Regulatory Affairs & IP | DUSA Pharmaceuticals Inc. (DUSA) | 16-Mar-12 | Market Option Sale | 17,500 | $5.78 | $101,097.00 | (8%) 228.59K to 211.09K | (38%) |
| 15-Mar-12 1:57 PM View: | Odell William F Exec. VP Sales and Marketing | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-12 | Payment of Exercise | 2,980 | $5.86 | $17,462.80 | (1%) 276.72K to 273.74K | (36%) |
| 15-Mar-12 1:59 PM View: | Todisco Michael Vice President, Controller | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-12 | Payment of Exercise | 2,203 | $5.86 | $12,909.60 | (1%) 173.4K to 171.19K | (36%) |
| 15-Mar-12 1:53 PM View: | Carota Mark Vice President, Operations | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-12 | Payment of Exercise | 2,203 | $5.86 | $12,909.60 | (1%) 191.36K to 189.16K | (36%) |
| 15-Mar-12 1:45 PM View: | Doman Robert F President and CEO Director | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-12 | Payment of Exercise | 7,418 | $5.86 | $43,469.50 | (1%) 695.36K to 687.94K | (36%) |
| 14-Mar-12 10:10 AM View: | Haft Jay M Director | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-12 | Option Exercise | 20,000 | $2.70 | $54,100.00 | 28% 70.5K to 90.5K | |
| 15-Mar-12 1:51 PM View: | Christopher Richard VP Finance & CFO | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-12 | Payment of Exercise | 2,980 | $5.86 | $17,462.80 | (1%) 272.52K to 269.54K | (36%) |
| 14-Mar-12 10:51 AM View: | Marcus Stuart L VP, Sc. Aff & CMO | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-12 | Payment of Exercise | 2,507 | $5.86 | $14,691.00 | (2%) 116.8K to 114.29K | (36%) |
| 15-Mar-12 1:48 PM View: | Lundahl Scott L VP, Regulatory Affairs & IP | DUSA Pharmaceuticals Inc. (DUSA) | 13-Mar-12 | Payment of Exercise | 2,203 | $5.86 | $12,909.60 | (1%) 213.29K to 211.09K | (36%) |
| 14-Mar-12 10:51 AM View: | Marcus Stuart L VP, Sc. Aff & CMO | DUSA Pharmaceuticals Inc. (DUSA) | 12-Mar-12 | Market Option Sale | 19,375 | $5.79 | $112,260.00 | (14%) 136.17K to 116.8K | (37%) |
| 14-Mar-12 10:51 AM View: | Marcus Stuart L VP, Sc. Aff & CMO | DUSA Pharmaceuticals Inc. (DUSA) | 12-Mar-12 | Option Exercise | 19,375 | $2.33 | $45,187.50 | 17% 116.8K to 136.17K | |
| 09-Mar-12 2:18 PM View: | Odell William F Exec. VP Sales and Marketing | DUSA Pharmaceuticals Inc. (DUSA) | 08-Mar-12 | Grant | 140,000 | -- | -- | 51% 273.44K to 413.44K | |
| 09-Mar-12 2:08 PM View: | Lundahl Scott L VP, Regulatory Affairs & IP | DUSA Pharmaceuticals Inc. (DUSA) | 08-Mar-12 | Grant | 95,000 | -- | -- | 40% 236.58K to 331.58K | |
| 09-Mar-12 2:21 PM View: | Todisco Michael Vice President, Controller | DUSA Pharmaceuticals Inc. (DUSA) | 08-Mar-12 | Grant | 80,000 | -- | -- | 43% 186.79K to 266.79K | |
| 08-Mar-12 4:06 PM View: | Bartash David M Director | DUSA Pharmaceuticals Inc. (DUSA) | 08-Mar-12 | Option Exercise | 25,000 | $2.90 | $72,500.00 | 81% 31.0K to 56.0K | |
| 09-Mar-12 2:42 PM View: | Doman Robert F President and CEO Director | DUSA Pharmaceuticals Inc. (DUSA) | 08-Mar-12 | Grant | 320,000 | -- | -- | 44% 730.97K to 1.05M |
